351 related articles for article (PubMed ID: 27460260)
1. Engineered Mesenchymal Stem Cells as an Anti-Cancer Trojan Horse.
Nowakowski A; Drela K; Rozycka J; Janowski M; Lukomska B
Stem Cells Dev; 2016 Oct; 25(20):1513-1531. PubMed ID: 27460260
[TBL] [Abstract][Full Text] [Related]
2. Revolutionizing Cancer Treatment: Harnessing the Power of Mesenchymal Stem Cells for Precise Targeted Therapy in the Tumor Microenvironment.
Taeb S; Rostamzadeh D; Amini SM; Rahmati M; Golshekan M; Abedinzadeh M; Ahmadi E; Neha S; Najafi M
Curr Top Med Chem; 2024 May; ():. PubMed ID: 38797895
[TBL] [Abstract][Full Text] [Related]
3. Mesenchymal stem cells engineered for cancer therapy.
Shah K
Adv Drug Deliv Rev; 2012 Jun; 64(8):739-48. PubMed ID: 21740940
[TBL] [Abstract][Full Text] [Related]
4. Current progress in engineered and nano-engineered mesenchymal stem cells for cancer: From mechanisms to therapy.
Shams F; Pourjabbar B; Hashemi N; Farahmandian N; Golchin A; Nuoroozi G; Rahimpour A
Biomed Pharmacother; 2023 Nov; 167():115505. PubMed ID: 37716113
[TBL] [Abstract][Full Text] [Related]
5. How desirable and undesirable features of naïve or genetically reengineered mesenchymal stem cells are being considered in preclinical or clinical assays.
González-Villarreal C; Guadalupe Martínez-Rodríguez H; Said-Fernández S
J BUON; 2017; 22(4):812-830. PubMed ID: 29155506
[TBL] [Abstract][Full Text] [Related]
6. Selective targeting of genetically engineered mesenchymal stem cells to tumor stroma microenvironments using tissue-specific suicide gene expression suppresses growth of hepatocellular carcinoma.
Niess H; Bao Q; Conrad C; Zischek C; Notohamiprodjo M; Schwab F; Schwarz B; Huss R; Jauch KW; Nelson PJ; Bruns CJ
Ann Surg; 2011 Nov; 254(5):767-74; discussion 774-5. PubMed ID: 22042469
[TBL] [Abstract][Full Text] [Related]
7. Concise review: genetically engineered stem cell therapy targeting angiogenesis and tumor stroma in gastrointestinal malignancy.
Keung EZ; Nelson PJ; Conrad C
Stem Cells; 2013 Feb; 31(2):227-35. PubMed ID: 23132810
[TBL] [Abstract][Full Text] [Related]
8. Linking transgene expression of engineered mesenchymal stem cells and angiopoietin-1-induced differentiation to target cancer angiogenesis.
Conrad C; Hüsemann Y; Niess H; von Luettichau I; Huss R; Bauer C; Jauch KW; Klein CA; Bruns C; Nelson PJ
Ann Surg; 2011 Mar; 253(3):566-71. PubMed ID: 21169810
[TBL] [Abstract][Full Text] [Related]
9. Human adipose tissue-derived mesenchymal stem cells: characteristics and therapeutic potential as cellular vehicles for prodrug gene therapy against brainstem gliomas.
Choi SA; Lee JY; Wang KC; Phi JH; Song SH; Song J; Kim SK
Eur J Cancer; 2012 Jan; 48(1):129-37. PubMed ID: 21664124
[TBL] [Abstract][Full Text] [Related]
10. Potential implications of mesenchymal stem cells in cancer therapy.
Dai LJ; Moniri MR; Zeng ZR; Zhou JX; Rayat J; Warnock GL
Cancer Lett; 2011 Jun; 305(1):8-20. PubMed ID: 21396770
[TBL] [Abstract][Full Text] [Related]
11. Mesenchymal stem cells as cellular vehicles for prodrug gene therapy against tumors.
Amara I; Touati W; Beaune P; de Waziers I
Biochimie; 2014 Oct; 105():4-11. PubMed ID: 24977933
[TBL] [Abstract][Full Text] [Related]
12. Mesenchymal Stromal/Stem Cells: A New Era in the Cell-Based Targeted Gene Therapy of Cancer.
Marofi F; Vahedi G; Biglari A; Esmaeilzadeh A; Athari SS
Front Immunol; 2017; 8():1770. PubMed ID: 29326689
[TBL] [Abstract][Full Text] [Related]
13. New Insights Into Implementation of Mesenchymal Stem Cells in Cancer Therapy: Prospects for Anti-angiogenesis Treatment.
Javan MR; Khosrojerdi A; Moazzeni SM
Front Oncol; 2019; 9():840. PubMed ID: 31555593
[TBL] [Abstract][Full Text] [Related]
14. Nano-engineered mesenchymal stem cells as targeted therapeutic carriers.
Sadhukha T; O'Brien TD; Prabha S
J Control Release; 2014 Dec; 196():243-51. PubMed ID: 25456830
[TBL] [Abstract][Full Text] [Related]
15. The future of mesenchymal stem cell-based therapeutic approaches for cancer - From cells to ghosts.
Mohr A; Zwacka R
Cancer Lett; 2018 Feb; 414():239-249. PubMed ID: 29175461
[TBL] [Abstract][Full Text] [Related]
16. Mesenchymal stem cells and cancer: tumor-specific delivery vehicles or therapeutic targets?
Dwyer RM; Kerin MJ
Hum Gene Ther; 2010 Nov; 21(11):1506-12. PubMed ID: 20649487
[TBL] [Abstract][Full Text] [Related]
17. Deepening a Simple Question: Can MSCs Be Used to Treat Cancer?
Gomes JPA; Assoni AF; Pelatti M; Coatti G; Okamoto OK; Zatz M
Anticancer Res; 2017 Sep; 37(9):4747-4758. PubMed ID: 28870893
[TBL] [Abstract][Full Text] [Related]
18. VCAM-1+ placenta chorionic villi-derived mesenchymal stem cells display potent pro-angiogenic activity.
Du W; Li X; Chi Y; Ma F; Li Z; Yang S; Song B; Cui J; Ma T; Li J; Tian J; Yang Z; Feng X; Chen F; Lu S; Liang L; Han ZB; Han ZC
Stem Cell Res Ther; 2016 Apr; 7():49. PubMed ID: 27044487
[TBL] [Abstract][Full Text] [Related]
19. Gene therapy using TRAIL-secreting human umbilical cord blood-derived mesenchymal stem cells against intracranial glioma.
Kim SM; Lim JY; Park SI; Jeong CH; Oh JH; Jeong M; Oh W; Park SH; Sung YC; Jeun SS
Cancer Res; 2008 Dec; 68(23):9614-23. PubMed ID: 19047138
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic Development of Mesenchymal Stem Cells or Their Extracellular Vesicles to Inhibit Autoimmune-Mediated Inflammatory Processes in Systemic Lupus Erythematosus.
Sharma J; Hampton JM; Valiente GR; Wada T; Steigelman H; Young MC; Spurbeck RR; Blazek AD; Bösh S; Jarjour WN; Young NA
Front Immunol; 2017; 8():526. PubMed ID: 28539924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
